These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 1132116)

  • 1. Systemic hemodynamic effects of bethanidine in essential hypertension.
    Chrysant SG; Nishiyama K; Adamopoulos PN; Frohlich ED
    Circulation; 1975 Jul; 52(1):137-40. PubMed ID: 1132116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bethanidine dose, plasma levels, and antihypertensive effects.
    Corder CN
    J Clin Pharmacol; 1978; 18(5-6):249-58. PubMed ID: 641213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiclinic controlled trial of bethanidine and guanethidine in severe hypertension.
    Ramirez EA; Elson L; Gear AS; Oster JR; Talmers FN; Thomas JR
    Circulation; 1977 Mar; 55(3):519-25. PubMed ID: 319922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of ventricular fibrillation and positive inotropic action of bethanidine sulfate, a chemical analog of bretylium tosylate that is well absorbed orally.
    Bacaner MB; Hoey MF; Macres MG
    Am J Cardiol; 1982 Jan; 49(1):45-55. PubMed ID: 7053610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electrophysiologic and hemodynamic effects of bethanidine sulfate on the immature mammalian heart.
    Fournier A; Young ML; Stolfi A; Gelband H; Pickoff AS
    Dev Pharmacol Ther; 1988; 11(5):288-96. PubMed ID: 3191821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiarrhythmic, antifibrillatory, and hemodynamic actions of bethanidine sulfate: an orally effective analog of bretylium for suppression of ventricular tachyarrhythmias.
    Bacaner MB; Benditt DG
    Am J Cardiol; 1982 Oct; 50(4):728-34. PubMed ID: 6812406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemodynamic effects of intravenous labetalol in essential hypertension.
    Dunn FG; Oigman W; Messerli FH; Dreslinski GR; Reisin E; Frohlich ED
    Clin Pharmacol Ther; 1983 Feb; 33(2):139-43. PubMed ID: 6822026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patterns of blood-pressure during chronic administration of postganglionic sympathetic blocking drugs for hypertension.
    Goldberg AD; Raftery EB
    Lancet; 1976 Nov; 2(7994):1052-4. PubMed ID: 62901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of hypertension with propranolol.
    Prichard BN; Gillam PM
    Br Med J; 1969 Jan; 1(5635):7-16. PubMed ID: 5761914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carvedilol in hypertension: effects on hemodynamics and 24-hour blood pressure.
    Lund-Johansen P; Omvik P; Nordrehaug JE; White W
    J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S27-34. PubMed ID: 1378146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute electrophysiologic effects of bethanidine sulfate in patients with ventricular tachycardia or fibrillation.
    DiMarco JP; Sellers TD; Shipe JR; Savory J; Spyker DH
    Am Heart J; 1984 Nov; 108(5):1244-9. PubMed ID: 6496282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The discovery of bretylium and bethanidine.
    Green AF
    Br J Clin Pharmacol; 1982 Jan; 13(1):25-34. PubMed ID: 7066153
    [No Abstract]   [Full Text] [Related]  

  • 13. Antiarrhythmic action of bethanidine.
    Somberg JC; Butler B; Torres V; Flowers D; Tepper D; Wynn J; Keren G; Miura DS
    Am J Cardiol; 1984 Aug; 54(3):343-6. PubMed ID: 6465015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pharmacological effects of [(octahydro-2-azocinyl)methyl] guanidine(guanazodine): its action mechanism and hypotensive effect].
    Shimizu T; Hamakawa H; Tozuka T; Ono H
    Nihon Yakurigaku Zasshi; 1976 Oct; 72(7):837-50. PubMed ID: 1035187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison and an investigation of a potential synergistic effect of labetalol and bethanidine in patients with mild hypertension.
    Chalmers AG; Hunter J; Lees CD; Millar JA; Brown JJ; Robertson JI
    Br J Clin Pharmacol; 1979; 8(Suppl 2):183S-187S. PubMed ID: 526399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic and renal hemodynamic effects of trimazosin: a new vasodilator.
    Chrysant SG; Luu TM; Danisa K; Kem DC; Manion CV
    J Cardiovasc Pharmacol; 1980; 2(2):205-14. PubMed ID: 6171687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of topically applied bethanidine on intraocular pressure and pupil in the rabbit.
    Krieglstein GK
    Albrecht Von Graefes Arch Klin Exp Ophthalmol; 1975 Aug; 196(1):31-8. PubMed ID: 1080636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sequential haemodynamic effects of labetalol at rest and during exercise in essential hypertension.
    Svendsen TL; Rasmussen S; Hartling OJ; Nielsen PE; Trap-Jensen J
    Postgrad Med J; 1980; 56 Suppl 2():21-6. PubMed ID: 7433338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A within-patient comparison of bethanidine, methyldopa and propranolol in the treatment of hypertension.
    Prichard BN; Boakes AJ; Graham BR
    Clin Sci Mol Med Suppl; 1976 Dec; 3():567s-570s. PubMed ID: 799566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors predisposing to postural hypotensive symptoms in the treatment of high blood pressure.
    Talbot S; Smith AJ
    Br Heart J; 1975 Oct; 37(10):1059-63. PubMed ID: 127594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.